Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.

Saved in:
Bibliographic Details
Title: Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.
Authors: Pratt SE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Pratt_Susan_E@lilly.com, Durland-Busbice S, Shepard RL, Donoho GP, Starling JJ, Wickremsinhe ER, Perkins EJ, Dantzig AH
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2013 Apr; Vol. 12 (4), pp. 481-90. Date of Electronic Publication: 2013 Jan 31.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23371859
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pratt+SE%22">Pratt SE</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Pratt_Susan_E@lilly.com<br /><searchLink fieldCode="AU" term="%22Durland-Busbice+S%22">Durland-Busbice S</searchLink><br /><searchLink fieldCode="AU" term="%22Shepard+RL%22">Shepard RL</searchLink><br /><searchLink fieldCode="AU" term="%22Donoho+GP%22">Donoho GP</searchLink><br /><searchLink fieldCode="AU" term="%22Starling+JJ%22">Starling JJ</searchLink><br /><searchLink fieldCode="AU" term="%22Wickremsinhe+ER%22">Wickremsinhe ER</searchLink><br /><searchLink fieldCode="AU" term="%22Perkins+EJ%22">Perkins EJ</searchLink><br /><searchLink fieldCode="AU" term="%22Dantzig+AH%22">Dantzig AH</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2013 Apr; Vol. 12 (4), pp. 481-90. <i>Date of Electronic Publication: </i>2013 Jan 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23371859
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-12-0654
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 481
    Titles:
      – TitleFull: Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pratt SE
      – PersonEntity:
          Name:
            NameFull: Durland-Busbice S
      – PersonEntity:
          Name:
            NameFull: Shepard RL
      – PersonEntity:
          Name:
            NameFull: Donoho GP
      – PersonEntity:
          Name:
            NameFull: Starling JJ
      – PersonEntity:
          Name:
            NameFull: Wickremsinhe ER
      – PersonEntity:
          Name:
            NameFull: Perkins EJ
      – PersonEntity:
          Name:
            NameFull: Dantzig AH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2013 Apr
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1